Retension Pharmaceuticals
RTSN
#9759
Rank
A$0.14 B
Marketcap
A$17.73
Share price
1.08%
Change (1 day)
N/A
Change (1 year)

Retension Pharmaceuticals (RTSN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$45.31 Million

According to Retension Pharmaceuticals's latest financial reports the company's total liabilities are A$45.31 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Retension Pharmaceuticals - Total liabilities on balance sheet (from 2025 to 2026)